FUM Intrinsic Valuation and Fundamental Analysis - Futura Medical PLC - Alpha Spread

Futura Medical PLC
LSE:FUM

Watchlist Manager
Futura Medical PLC Logo
Futura Medical PLC
LSE:FUM
Watchlist
Price: 32.55 GBX -3.56% Market Closed
Market Cap: 98.3m GBX
Have any thoughts about
Futura Medical PLC?
Write Note

Intrinsic Value

The intrinsic value of one FUM stock under the Base Case scenario is 11.67 GBX. Compared to the current market price of 32.55 GBX, Futura Medical PLC is Overvalued by 64%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

FUM Intrinsic Value
11.67 GBX
Overvaluation 64%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Futura Medical PLC

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for FUM cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about FUM?
Bearish
Neutral
Bullish

Fundamental Analysis

Summary

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

AI Assistant
AI Assistant
Ask me anything about Futura Medical PLC

Provide an overview of the primary business activities
of Futura Medical PLC.

What unique competitive advantages
does Futura Medical PLC hold over its rivals?

What risks and challenges
does Futura Medical PLC face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Futura Medical PLC.

Provide P/S
for Futura Medical PLC.

Provide P/E
for Futura Medical PLC.

Provide P/OCF
for Futura Medical PLC.

Provide P/FCFE
for Futura Medical PLC.

Provide P/B
for Futura Medical PLC.

Provide EV/S
for Futura Medical PLC.

Provide EV/GP
for Futura Medical PLC.

Provide EV/EBITDA
for Futura Medical PLC.

Provide EV/EBIT
for Futura Medical PLC.

Provide EV/OCF
for Futura Medical PLC.

Provide EV/FCFF
for Futura Medical PLC.

Provide EV/IC
for Futura Medical PLC.

Show me price targets
for Futura Medical PLC made by professional analysts.

What are the Revenue projections
for Futura Medical PLC?

How accurate were the past Revenue estimates
for Futura Medical PLC?

What are the Net Income projections
for Futura Medical PLC?

How accurate were the past Net Income estimates
for Futura Medical PLC?

What are the EPS projections
for Futura Medical PLC?

How accurate were the past EPS estimates
for Futura Medical PLC?

What are the EBIT projections
for Futura Medical PLC?

How accurate were the past EBIT estimates
for Futura Medical PLC?

Compare the revenue forecasts
for Futura Medical PLC with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Futura Medical PLC and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Futura Medical PLC against its competitors.

Analyze the profit margins
(gross, operating, and net) of Futura Medical PLC compared to its peers.

Compare the P/E ratios
of Futura Medical PLC against its peers.

Discuss the investment returns and shareholder value creation
comparing Futura Medical PLC with its peers.

Analyze the financial leverage
of Futura Medical PLC compared to its main competitors.

Show all profitability ratios
for Futura Medical PLC.

Provide ROE
for Futura Medical PLC.

Provide ROA
for Futura Medical PLC.

Provide ROIC
for Futura Medical PLC.

Provide ROCE
for Futura Medical PLC.

Provide Gross Margin
for Futura Medical PLC.

Provide Operating Margin
for Futura Medical PLC.

Provide Net Margin
for Futura Medical PLC.

Provide FCF Margin
for Futura Medical PLC.

Show all solvency ratios
for Futura Medical PLC.

Provide D/E Ratio
for Futura Medical PLC.

Provide D/A Ratio
for Futura Medical PLC.

Provide Interest Coverage Ratio
for Futura Medical PLC.

Provide Altman Z-Score Ratio
for Futura Medical PLC.

Provide Quick Ratio
for Futura Medical PLC.

Provide Current Ratio
for Futura Medical PLC.

Provide Cash Ratio
for Futura Medical PLC.

What is the historical Revenue growth
over the last 5 years for Futura Medical PLC?

What is the historical Net Income growth
over the last 5 years for Futura Medical PLC?

What is the current Free Cash Flow
of Futura Medical PLC?

Discuss the annual earnings per share (EPS)
trend over the past five years for Futura Medical PLC.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Futura Medical PLC

Current Assets 9.1m
Cash & Short-Term Investments 7.8m
Receivables 1.2m
Other Current Assets 66k
Non-Current Assets 1.1m
PP&E 1.1m
Current Liabilities 2.2m
Accounts Payable 675.2k
Accrued Liabilities 876k
Other Current Liabilities 644.1k
Efficiency

Earnings Waterfall
Futura Medical PLC

Revenue
8.4m GBP
Cost of Revenue
-2.7m GBP
Gross Profit
5.7m GBP
Operating Expenses
-9.9m GBP
Operating Income
-4.2m GBP
Other Expenses
432.8k GBP
Net Income
-3.8m GBP

Free Cash Flow Analysis
Futura Medical PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

FUM Profitability Score
Profitability Due Diligence

Futura Medical PLC's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

Exceptional Revenue Growth Forecast
Exceptional 1-Year Revenue Growth
ROIC is Increasing
Positive Gross Profit
28/100
Profitability
Score

Futura Medical PLC's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

FUM Solvency Score
Solvency Due Diligence

Futura Medical PLC's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

Futura Medical PLC's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

FUM Price Targets Summary
Futura Medical PLC

Wall Street analysts forecast FUM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for FUM is 138.21 GBX with a low forecast of 132.31 GBX and a high forecast of 147 GBX.

Lowest
Price Target
132.31 GBX
306% Upside
Average
Price Target
138.21 GBX
325% Upside
Highest
Price Target
147 GBX
352% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for FUM?

Click here to dive deeper.

Dividends

Futura Medical PLC
does not pay dividends
Shareholder Yield

Current shareholder yield for FUM is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Futura Medical PLC Logo
Futura Medical PLC

Country

United Kingdom

Industry

Pharmaceuticals

Market Cap

97.3m GBP

Dividend Yield

0%

Description

Futura Medical Plc is a pharmaceutical group that develops products for both the prescription and consumer healthcare markets. The company is headquartered in Guildford, Surrey and currently employs 13 full-time employees. The company went IPO on 2006-07-10. The firm is focused on developing a portfolio of products based on its transdermal DermaSys technology. Its patented transdermal DermaSys technology provides rapid and targeted local delivery of medical treatments via the skin. The firm is engaged in developing a portfolio of products for therapeutic areas, such as sexual health, including erectile dysfunction, and pain relief. The firm's products include MED3000 and TPR100. The firm's lead product, MED3000, is a topical gel formulation treatment for erectile dysfunction (ED) through an evaporative mode of action. The firm has conducted a Phase III study using MED3000 in ED. TPR100 is a topical non-steroidal anti-inflammatory for the pain and inflammation associated with sprains, strains and bruises and soft tissue rheumatism.

Contact

SURREY
Guildford
Unit 40, Surrey Technology Centre, Occam Road
+441483685670.0
www.futuramedical.com

IPO

2006-07-10

Employees

13

Officers

See Also

Discover More
What is the Intrinsic Value of one FUM stock?

The intrinsic value of one FUM stock under the Base Case scenario is 11.67 GBX.

Is FUM stock undervalued or overvalued?

Compared to the current market price of 32.55 GBX, Futura Medical PLC is Overvalued by 64%.

Back to Top